3 Cathie Wood Stocks That Could More Than Double in 12 Months, According to Wall Street
These stocks are risky. But they just might deliver huge gains if analysts are right.
Stay updated with breaking news from Compass Pathways. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
These stocks are risky. But they just might deliver huge gains if analysts are right.
Transcranial magnetic stimulation is associated with reductions in both anxiety and depression scores in patients with both disorders, a large new analysis shows.
This article by James Hallifax was originally published on Microdose and appears here with permission. 2022 was a milestone year for th...
Ongoing studies point to legitimate uses for mushrooms, ketamine, LSD and other such street drugs to treat challenging mental health conditions.
Investegate announcements from COMPASS Pathways, COMP360 psilocybin therapy shows potential in open-label study in type II bipolar disorder presented at ACNP